ACTEMRA 162MG INJECTION

Actemra 162mg injection is a source of an active ingredient called tocilizumab. It is the monoclonal antibody group (a protein derived from specific immune cells). This medicine is utilized in cases such as severe to moderately active arthritis (RA) and sufferers who have no response to other drugs for rheumatoid arthritis, such as giant cell arteritis (disease in the arteries), as well as children with systemic juvenile Idiopathic arthritis  and polyarticular juvenile Idiopathic Arthritis  which cause swelling and pain in some or all joints in children aged 1 to 2 years old and over.
Children who experience allergic reactions to the ingredients or severe infections should talk to their doctor before taking the medication. Consult your physician immediately when you experience any allergic reaction (difficulty breathing, tightness in your chest and itching, hives, swelling of the tongue, lips, or the face) or infections (short long-term) tuberculosis, intestinal diverticulitis or ulcers (small bulging pouches that form within the digestive tract) liver diseases, cancer kidney function issues, and chronic headaches.
Inform your physician if children have any history of having macrophage activation disorder (activation and uncontrolled growth of specific white blood cells). The elderly are more prone to diseases than people of all ages. Therefore, it is essential to be aware of treating those with these diseases. Check with your physician if you are planning to have a baby or suspect you are pregnant or nursing.